A. G. P. Maintains Quantum-Si(QSI.US) With Buy Rating, Cuts Target Price to $3.65
Quantum-Si's Strategic Growth and Financial Strength Drive Buy Rating
H.C. Wainwright Maintains Quantum-Si(QSI.US) With Buy Rating, Maintains Target Price $5.5
Quantum-Si Analyst Ratings
Alliance Global Partners Initiates Coverage On Quantum-Si With Buy Rating, Announces Price Target of $3.75
A. G. P. Initiates Quantum-Si(QSI.US) With Buy Rating, Announces Target Price $3.75
Quantum-Si Analyst Ratings
H.C. Wainwright Maintains Quantum-Si(QSI.US) With Buy Rating, Maintains Target Price $5.5
Quantum-Si's Promising Outlook With Platinum Pro Launch and Buy Rating Justification
CCORF Maintains Quantum-Si(QSI.US) With Hold Rating, Maintains Target Price $1
H.C. Wainwright Maintains Quantum-Si(QSI.US) With Buy Rating, Raises Target Price to $5.5
Quantum-Si Is Maintained at Buy by HC Wainwright & Co.
Quantum-Si's Strategic Advancements and Innovations Drive Buy Rating
Quantum-Si Analyst Ratings
Quantum-Si Is Maintained at Hold by Canaccord Genuity
Quantum-Si Analyst Ratings
CCORF Maintains Quantum-Si(QSI.US) With Hold Rating, Cuts Target Price to $1
Buy Rating Affirmed for Quantum-Si on Strong Financials and Promising Product Pipeline
Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX)
Quantum-Si Analyst Ratings